Form 8-K - Current report:
SEC Accession No. 0001140361-21-039510
Filing Date
2021-11-26
Accepted
2021-11-26 16:05:34
Documents
12
Period of Report
2021-11-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K brhc10031117_8k.htm   iXBRL 8-K 22607
  Complete submission text file 0001140361-21-039510.txt   156775

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ions-20211126.xsd EX-101.SCH 3932
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20211126_lab.xml EX-101.LAB 22544
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20211126_pre.xml EX-101.PRE 16048
5 EXTRACTED XBRL INSTANCE DOCUMENT brhc10031117_8k_htm.xml XML 4072
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 211451939
SIC: 2834 Pharmaceutical Preparations